Alkermes plc
NASDAQ: ALKS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard F. Pops
- Employees
- 2,095
- Headquarters
- Dublin, Ireland
- IPO year
- 1991
- Market cap
- $8.6B
- Website
- http://www.alkermes.com
Loading ALKS…
Loading profile data…Frequently asked questions about ALKS
What does Alkermes plc (ALKS) do?
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence...
Where does ALKS trade?
Alkermes plc (ALKS) trades on the NASDAQ.
What sector is ALKS in?
Alkermes plc (ALKS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Alkermes plc?
Richard F. Pops is the chief executive officer of Alkermes plc (ALKS).
Where is Alkermes plc headquartered?
Alkermes plc is headquartered in Ireland.
Does ALKS pay a dividend?
Alkermes plc (ALKS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALKS go public?
Alkermes plc (ALKS) completed its initial public offering in 1991.